查找临床试验
已按「克罗恩病」检索，对应国际通用词 Crohn disease
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 10:03，每 5 分钟自动同步Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety
China
年龄 18 Years – 65 Years
Sixth Affiliated Hospital, Sun Yat-sen University
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
United States、Australia、Austria、Belgium、Brazil 等 12 国
年龄 16 Years – 80 Years
Merck Sharp & Dohme LLC
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
United States、Belgium、Bulgaria、Canada、China 等 12 国
年龄 2 Years – 17 Years
AbbVie
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease
China
年龄 18 Years – 85 Years
Shanghai 10th People's Hospital
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
China
年龄 18 Years – 不限
Xian-Janssen Pharmaceutical Ltd.
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 16 Years – 80 Years
Hoffmann-La Roche
Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.
China
年龄 18 Years – 65 Years
Xiang Gao
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
China
年龄 18 Years – 80 Years
Takeda
Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
China
年龄 18 Years – 70 Years
Sixth Affiliated Hospital, Sun Yat-sen University
Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus Intensified Ustekinumab Therapy in Crohn's Disease
China
年龄 18 Years – 70 Years
Sixth Affiliated Hospital, Sun Yat-sen University
GWA Study in Patients With Inflammatory Bowel Disease
Hong Kong
年龄 18 Years – 不限
Chinese University of Hong Kong
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
China
年龄 2 Years – 16 Years
Biao Zou